# Inhaled Iloprost for the Treatment of Persistent Pulmonary Hypertension in the Term and Near Term Infants.

> **NCT00409526** · PHASE4 · TERMINATED · sponsor: **University of Chicago** · enrollment: 1 (actual)

## Conditions studied

- Pulmonary Hypertension

## Interventions

- **DRUG:** Inhaled Iloprost

## Key facts

- **NCT ID:** NCT00409526
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-12
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Sub-Investigator left U of C
- **Last updated:** 2014-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00409526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00409526, "Inhaled Iloprost for the Treatment of Persistent Pulmonary Hypertension in the Term and Near Term Infants.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00409526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*